Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s348143
Abstract: Background Many medications used to treat schizophrenia and bipolar I disorder are linked to hyperprolactinemia. The effects of cariprazine, a dopamine D3/D2 receptor partial agonist, on prolactin levels in patients with schizophrenia or bipolar I… read more here.
Keywords: week duration; prolactin levels; bipolar disorder; prolactin ... See more keywords